New Technology Ventures

New Technology Ventures Enet October 4, 2016

NTV Management, Inc.

NTV’s Mission and Approach

NTV emphasizes spinning out companies based  on well developed technologies from our  partners, benefitting from substantial previous  R&D investment and de‐risking, to maximize  stakeholder value.  

“We Build Companies, Not Just  Manage Capital” 2

NTV’s team has what it takes to create success

• Deep investment experience in technology, cybersecurity, and healthcare over the last 20+ years • Strong leadership, management, and technical knowledge from 100+ collective years of public, private and government sector experience • Complementary expertise in fund and business management, commercial and scientific assessment, technology development, and sophisticated investment across all stages to exit • Extensive network including leading companies, universities, national laboratories, and innovators for sourcing and vetting opportunities • Outstanding track record of creating value through investment and entrepreneurial excellence

3

Disciplined operating model combines active management and strategic best practices

VC Individual Investors Opportunistic 1 in 10 Model

PE Small to Big Process Oriented

Financial Engineers Leveraged Quick Flip

Reduce Technology Risk Team Oriented Hands On Innovative New

Value Network Objectives: Further Reduce Technology Risk Identify Gaps & Shortfalls Integrate & Develop Technologies

Intellectual Capital Investment of Time & Intangibles Value Network Innovation

Accelerator

Strategic Values: Accept & Reduce Risk Utilize a Partnership Model Take the long view

4

Our team: Seasoned Professionals, Investors, Technologists, Entrepreneurs, and Leaders Charles Bridge –Managing Director, CFO, General Partner • • •

20+ years private equity, venture capital experience and Investment, with 50+ investments. Founding General Partner of Brooke Private Equity Associates, $1B in AUM. General Partner and CFO of Boston Capital Ventures; CFO MPM Capital.

David Hendren – Managing Director, Managing General Partner • • •

25+ years venture capital, entrepreneurship, deal, operating, and advisory experience in healthcare and technology.  Founder and General Partner of Catalyst Health Ventures, $70M investment/$450+M co‐investment, M&A, IPOs. Incubation and spin‐off experience includes GI Dynamics, Vortex Medical, Angstrom Medica, and Accountable Care  Associates.

Starnes Walker, PhD – Managing Director, CTO, GP • • • • •

Internationally‐recognized expert in technology development and application with 30+ years of leadership experience. Founding Director‐University of Delaware Cybersecurity Initiative & Professor‐Electrical & Computer Engineering Former Chief Technology Officer for the U.S. Fleet Cyber Command & U.S. 10th Fleet, U.S. Navy.  Former Director of Research in the Science and Technology Directorate of the U.S. Department of Homeland Security Science Advisor to Lawrence Livermore National Laboratory and  Los Alamos National Laboratory

Chris Whalen – Managing Director, Partner • • • •

20+ years of venture capital, entrepreneurship, innovation and operating experience IP monetization at NEC Labs Start‐up experience includes COGO, CatalystOne, Links2Go, Cambiotech, and Multiply Corporation Investment Banking including Spouting Rock, Progress Partners, and WACM 5

Our team: Seasoned Professionals, Investors, Technologists, Entrepreneurs, and Leaders Bob Bozeman – Special Partner • 25+ years of venture capital experience including 530 Angels, Eastlake Ventures, and Angel Investors,  LP   • First venture capital money into Google (168X), Pay Pal, Ask Jeeves (52X), RedEnvelope • Former CEO of Acer/Altos (Americas) and executive at Wang Laboratories  ML Carr– Special Partner • 40 years varied professional, leadership, and business experience • All‐American, NAIA Basketball Champion and 12 years in NBA including 2 NBA Championships with  Boston Celtics • Coaching and Management of Boston Celtics and Charlotte Bobcats • Extensive business and professional networks. • Boards including CBS Channel 7 (Boston), New Balance, BioDirection, and Davis Lee Companies. Hal Chapel– Venture and Operating Partner • 35+ years entrepreneurship, leadership, and operating experience in IT and healthcare • Founder/CEO of venture‐backed companies including Vanguard Business Solutions, Xevo, Lotsa Helping Hands, QKD, Inc. • Recognized tech visionary in DB systems, OSS/BSS, business process, and healthcare aging sector • Extensive business development with industry leaders including Microsoft, Citrix, Intel, Cisco, GE,  TRW, Transamerica, AT&T, British Telecom, United Healthcare, Pfizer 

6

Our team: World-Class Advisors The Honorable Jay M. Cohen, Rear Admiral (Retired) • Under Secretary for Science and Technology, U.S.  Department of Homeland Security. • Chief of Naval Research, Department of the Navy. • Director, Navy Y2K Office. • Deputy Chief of Navy Legislative Affairs. Elazer R. Edelman, M.D., Ph.D. • Director of Harvard‐MIT Biomedical Engineering Center. • Thomas D. and Virginia W. Cabot Professor of Health  Sciences and Technology at MIT. • Professor of Medicine at Harvard Medical School. • Fellow, American College of Cardiology, American Heart  Association, Association of University Cardiologists,  American Society of Clinical Investigation, American  Institute of Medical and Biological Engineering, and the  Institute of Medicine and National Academy of Engineering. Valerie Mosley • Chairwoman and CEO of Valmo Ventures • 20+ years as Partner, SVP, and Investment Strategist,  Wellington Management Company • Director, Eaton Vance Fund Family, Dynex Capital, and  Progress Investment Management Company.

Gale S. Pollock CRNA, FACHE, FAAN Major General (Retired) • Acting Surgeon General of the United States Army. • Commander US Army Medical Command. • Commanding General, Tripler Army Medical Center, Pacific  Regional Medical Command; Commander, Martin Army  Community Hospital. • Fellow, Advanced Leadership Initiative at Harvard  University. • CEO, Elevio Inc. Brent Segal, PH.D. • Director of Advanced Research Programs at Lockheed  Martin. • Chief Scientist – Advanced Research Programs at Lockheed  Martin. • Co‐Founder and Chief Operating Officer Nantero. Frances Fragos Townsend • EVP MacAndrews & Forbes. • CNN National Security Analyst. • Assistant to the President for Homeland Security and  Counterterrorism. • US Department of Justice.

7

Deal selection: Disciplined criteria for investment and creation of new ventures Investment Criteria

Technologies with  Mitigated Risk

Compelling  Opportunities

• Significant prior R&D spend  and/or reduction of  technical risk

• 10X+ ‘order of magnitude’  improvements

• Minimal unresolved  scientific risk • Novel and defensible IP • Know‐how available to NTV • Ability to drive technology  into target markets and  create rapid commercial  success

• “Game changing” solutions  and ability to create or  disrupt markets  • High margin business  models • Large potential markets • Opportunity to build  profitable, sustainable  businesses and exits

Ability to Add Significant Value • NTV as entrepreneurial  driver, active partner  supporting management • Corporate partnerships • IP augmentation – close  ties to top universities/labs • Active Board participation • Meaningful role in building  and driving strategy • Broad EIR network 8

Sophisticated network provides NTV with access to the best private and public innovators NTV leverages credibility and experience with top-tier universities, academic medical and research centers, national laboratories, intelligence agencies, and corporations to access and commercialize well-funded, de-risked, cutting-edge technology and IP

Corporate R&D

National Security  Agencies

Top Tier Universities    and Labs

9